Screener

Eligibility screening

TSC-100 and TSC-101 in AML, ALL and MDS in Patients Undergoing Allogeneic Peripheral Blood Stem Transplantation

Sponsored by TScan Therapeutics, Inc.Study detailsClinicalTrials.gov

15 US sites in CA, CT, FL, GA +9

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.